TIGIT and CD155 as Immune-Modulator Receptor and Ligand on CD4

CD4-Positive T-Lymphocytes Case-Control Studies Cytokines / metabolism Female Forkhead Transcription Factors / metabolism Humans Interleukin-10 / genetics Interleukin-17 / metabolism Leukocytes, Mononuclear / metabolism Ligands Pre-Eclampsia Pregnancy RNA, Messenger Receptors, Immunologic Receptors, Virus Transforming Growth Factor beta / metabolism Tumor Necrosis Factor-alpha / metabolism
CD155 Preeclampsia TIGIT inflammatory cytokine regulatory cytokine

Journal

Immunological investigations
ISSN: 1532-4311
Titre abrégé: Immunol Invest
Pays: England
ID NLM: 8504629

Informations de publication

Date de publication:
May 2022
Historique:
pubmed: 16 4 2021
medline: 3 6 2022
entrez: 15 4 2021
Statut: ppublish

Résumé

One of the main characteristics of preeclampsia (PE) is systemic inflammation. CD4

Identifiants

DOI: 10.1080/08820139.2021.1904976 PMID: 33855917
pubmed: 33855917
doi: 10.1080/08820139.2021.1904976
doi:

Substances chimiques

Cytokines 0
Forkhead Transcription Factors 0
Interleukin-17 0
Ligands 0
RNA, Messenger 0
Receptors, Immunologic 0
Receptors, Virus 0
TIGIT protein, human 0
Transforming Growth Factor beta 0
Tumor Necrosis Factor-alpha 0
poliovirus receptor 0
Interleukin-10 130068-27-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1023-1038

Auteurs

Amin Kamrani (A)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Immunology Department, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad Sadegh Soltani-Zangbar (MS)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Immunology Department, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID: 0000-0003-3960-5712

Sadaf Shiri (S)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Yousef Yousefzadeh (Y)

Immunology Department, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Ramin Pourakbari (R)

Immunology Department, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Leili Aghebati-Maleki (L)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID: 0000-0002-0044-5961

Amir Mehdizadeh (A)

Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Shahla Danaii (S)

Gynecology Department, Eastern Azerbaijan ACECR ART Center, Eastern Azerbaijan Branch of ACECR, Tabriz, Iran.

Farhad Jadidi-Niaragh (F)

Immunology Department, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Bahman Yousefi (B)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Hossein Samadi Kafil (HS)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID: 0000-0001-6026-8795

Mohammad Hojjat-Farsangi (M)

Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center. Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.
ORCID: 0000-0002-0589-5523

Roza Motavalli (R)

Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammadali Zolfaghari (M)

Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mostafa Haji-Fatahaliha (M)

Immunology Department, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Ata Mahmoodpoor (A)

Department of Anesthesiology, Tabriz University of Medical Sciences, Tabriz, Iran.

Javad Ahmadian Heris (J)

Department of Allergy and Clinical Immunology, Pediatric Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.

Asma Emdadi (A)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mehdi Yousefi (M)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Immunology Department, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD4+ › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études cas-témoins › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Facteurs de transcription à motif hélice ailée › Facteurs de transcription Forkhead › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Interleukines › Interleukine-10 › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Interleukines › Interleukine-17 › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Ligands › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Maladies urogénitales › Maladies de l'appareil urogénital féminin et complications de la grossesse › Complications de la grossesse › Pré-éclampsie › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Reproduction › Grossesse › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN messager › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs viraux › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Protéines de la superfamille du TGF bêta › Facteur de croissance transformant bêta › TIGIT and CD155 as Immune-Modulator Receptor...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Facteurs de nécrose tumorale › Facteur de nécrose tumorale alpha › TIGIT and CD155 as Immune-Modulator Receptor...